Health & Fitness
Thu, March 29, 2012
LONG BEACH, Calif.--([ BUSINESS WIRE ])--Obagi Medical Products, Inc. (NASDAQ: OMPI), a leader in topical aesthetic and therapeutic skin health systems, today announced that Albert Hummel, the Companyas President and Chief Executive Officer will present a corporate overview at the 11th Annual Needham Healthcare Conference to be held at the New York Palace Hotel. The presentation will take place at 2:40 p.m. (EDT) on Wednesday, April 4, 2012.
A live webcast of the presentation will be available via the internet by visiting the Investor Relations section of the Company's web site at [ www.obagi.com ]. The archived presentation will be available on the web site for 30 days.
About Obagi Medical Products, Inc.
Obagi Medical Products is a specialty pharmaceutical company that develops, markets and sells, and is a leading provider of, proprietary topical aesthetic and therapeutic prescription-strength skin care systems in the physician-dispensed market. Using its Penetrating Therapeuticsa" technologies, Obagi Medical's products are designed to improve penetration of agents across the skin barrier for common and visible skin conditions in adult skin including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, rosacea, and soft tissue deficits, such as fine lines and wrinkles. Obagi Medicalas portfolio, which includes cosmetic, over-the-counter and prescription products, including 4% hydroquinone, is sold and promoted only through physician offices and requires education by a physician on proper use. The history of Obagi's skin care product introductions is as follows: Obagi Nu-Derm, Obagi-C Rx (a prescription-strength vitamin C and hydroquinone system), Obagi Professional-C (a line of highly stable vitamin C serums), Obagi Condition & Enhance for use with cosmetic procedures to enhance patient outcomes and satisfaction, Obagi ELASTIderm Eye Products and Obagi CLENZIderm M.D. acne therapeutic systems, a formulation of Obagi CLENZIderm M.D. Systems for normal to dry skin, and Obagi ELASTIderm Dcolletage System, Obagi Rosaclear System, Obagi ELASTILash Eyelash Solution, Obagi Blue Peel RADIANCE, and Nu-Derm Sun Shield SPF 50. Visit [ www.obagi.com ] for information.
Penetrating Therapeutics is a trademark, and Obagi, the Obagi logo, Blue Peel RADIANCE, Condition & Enhance, ELASTIderm, ELASTILash, Nu-Derm, Obagi-C, Obagi CLENZIderm and Rosaclear are registered trademarks, of Obagi Medical Products, Inc. and/or its affiliates in the United States and certain other countries.
